Department of Laboratory Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China; Central Laboratory and Department of Laboratory Medicine, Shanghai Tenth People's Hospital, Tongji University, Shanghai 200070, China.
Central Laboratory and Department of Laboratory Medicine, Shanghai Tenth People's Hospital, Tongji University, Shanghai 200070, China.
Clin Chim Acta. 2024 Mar 1;555:117802. doi: 10.1016/j.cca.2024.117802. Epub 2024 Jan 26.
BACKGROUND: The incidence of inflammatory bowel disease (IBD) continues to increase annually, accounting for about 6.8 million cases in 2017 worldwide. However, there is currently no gold standard for the diagnosis of IBD. METHODS: A method for the detection of four microorganisms in feces by two-dimensional polymerase chain reaction (2D-PCR) has been developed. Plasmids were used to validate the sensitivity and specificity of the method. Clinical samples were tested using a 2D-PCR method. Optimal diagnostic thresholds for IBD were determined based on ROC results. RESULTS: Of the 112 samples, 78 were from IBD patients and 34 from patients with other gastrointestinal (GI) diseases. Thomasclavelia ramosum and univ907-1062 positivity are necessary, and two or more positives of the three bacteria (Thomasclavelia spiroforme, Thomasclavelia saccharogumia or Clostridium cluster XVIII) are the optimal diagnostic thresholds for IBD. The area under the curve was 0.826 with a 95% confidence interval of 0.735-0.981 and a p-value of 0.000, corresponding to a sensitivity of 0.769 and a specificity of 0.853. CONCLUSIONS: Based on the detection results of microorganisms, IBD and GI can be effectively distinguished. The detection of four microorganisms in feces can assist clinicians in the differential diagnosis of IBD. Our experiment aims to provide a better program for early clinical diagnosis and regular dynamic monitoring of IBD.
背景:炎症性肠病(IBD)的发病率持续上升,2017 年全球约有 680 万例。然而,目前 IBD 的诊断尚无金标准。
方法:建立了一种通过二维聚合酶链反应(2D-PCR)检测粪便中四种微生物的方法。使用质粒验证该方法的灵敏度和特异性。采用 2D-PCR 法检测临床样本。根据 ROC 结果确定 IBD 的最佳诊断阈值。
结果:在 112 个样本中,78 个来自 IBD 患者,34 个来自其他胃肠道(GI)疾病患者。Thomasclavelia ramosum 和 univ907-1062 阳性是必要的,三种细菌(Thomasclavelia spiroforme、Thomasclavelia saccharogumia 或 Clostridium cluster XVIII)中两种或两种以上阳性是 IBD 的最佳诊断阈值。曲线下面积为 0.826,95%置信区间为 0.735-0.981,p 值为 0.000,对应灵敏度为 0.769,特异性为 0.853。
结论:基于微生物检测结果,可以有效区分 IBD 和 GI。粪便中四种微生物的检测可辅助临床医生对 IBD 进行鉴别诊断。我们的实验旨在为 IBD 的早期临床诊断和定期动态监测提供更好的方案。
Int J Syst Evol Microbiol. 2023-2
Mod Pathol. 2023-7